CG
ELV icon

Carmignac Gestion’s Elevance Health ELV Stock Holding History

Carmignac Gestion’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,176
Closed -$512K – 143
2025
Q1 		$512K Sell
1,176
-461,600
-100% -$185M 0.01% 133
2024
Q4 		$171M Buy
462,776
+148,200
+47% +$62M 2.72% 14
2024
Q3 		$164M Buy
314,576
+192,150
+157% +$103M 2.73% 13
2024
Q2 		$66.3M Buy
+122,426
New +$64.7M 1.14% 23
2023
Q3 		– Sell
-43,665
Closed -$19.4M – 152
2023
Q2 		$19.4M Sell
43,665
-264,698
-86% -$122M 0.33% 49
2023
Q1 		$142M Sell
308,363
-141,176
-31% -$67.2M 2.36% 17
2022
Q4 		$231M Sell
449,539
-29,585
-6% -$15M 4.17% 6
2022
Q3 		$218M Sell
479,124
-26,883
-5% -$12.9M 4.68% 6
2022
Q2 		$244M Sell
506,007
-100,321
-17% -$49.6M 5.17% 4
2022
Q1 		$298M Sell
606,328
-129,768
-18% -$59.3M 4.81% 6
2021
Q4 		$341M Sell
736,096
-55,054
-7% -$23.2M 4.77% 6
2021
Q3 		$295M Sell
791,150
-2,570
-0.3% -$977K 3.68% 8
2021
Q2 		$303M Sell
793,720
-126,914
-14% -$48.5M 3.51% 8
2021
Q1 		$330M Buy
920,634
+1,272
+0.1% +$409K 3.79% 6
2020
Q4 		$295M Buy
919,362
+107,166
+13% +$32.9M 3.09% 7
2020
Q3 		$218M Sell
812,196
-2,303
-0.3% -$620K 2.58% 10
2020
Q2 		$214M Buy
814,499
+32,959
+4% +$8.79M 2.96% 9
2020
Q1 		$177M Sell
781,540
-226,775
-22% -$61.8M 3.03% 9
2019
Q4 		$305M Sell
1,008,315
-26,778
-3% -$7.37M 4.07% 6
2019
Q3 		$249M Buy
1,035,093
+9,814
+1% +$2.69M 3.14% 7
2019
Q2 		$289M Sell
1,025,279
-149,186
-13% -$40.8M 3.59% 6
2019
Q1 		$337M Buy
1,174,465
+197,289
+20% +$57.1M 3.93% 5
2018
Q4 		$257M Buy
977,176
+298,943
+44% +$82.2M 3.88% 8
2018
Q3 		$186M Buy
+678,233
New +$176M 1.58% 28

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Carmignac Gestion's ELV Position: Q2 2025 in Review

Carmignac Gestion sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,176 shares — an estimated $512K sold.

Carmignac Gestion first reported a position in ELV in Q3 2018 and held it in 24 quarters. The position peaked at $341M in Q4 2021. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Carmignac Gestion reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Carmignac Gestion sold 1,176 Elevance Health shares in Q2 2025, an estimated $512K.
  • Carmignac Gestion first reported a position in Elevance Health in Q3 2018 and held it in 24 quarters.
  • Carmignac Gestion's Elevance Health position peaked at $341M in Q4 2021.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Carmignac Gestion's 13F filing for Q2 2025, filed 13 Aug 2025.